top of page

NINLARO CAPSULE 2.3mg

Product details

Registration number: SIN15162P

Classification: Prescription Only

Active ingredients: Ixazomib citrate 3.3mg eqv ixazomib

Strength: 2.3mg

Dosage form: CAPSULE

Route: ORAL

Registrant: TAKEDA PHARMACEUTICALS (ASIA PACIFIC) PTE. LTD.

ATC code: L01XX50

HSA approval date: 20 January 2017

Manufacturer(s):

  • HAUPT PHARMA AMAREG GMBH
  • Takeda Ireland Ltd.

Manufacturing country/countries: IRELAND; GERMANY

What are the HSA registration number and classification for NINLARO CAPSULE 2.3mg?

According to the HSA dataset updated 7 August 2026:

Registration number: SIN15162P

Classification: Prescription Only

Source for this answer

What active ingredients and strength are recorded for NINLARO CAPSULE 2.3mg?

According to the HSA dataset updated 7 August 2026:

Active ingredients: Ixazomib citrate 3.3mg eqv ixazomib

Strength: 2.3mg

Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.

Source for this answer

What dosage form and route are recorded for NINLARO CAPSULE 2.3mg?

According to the HSA dataset updated 7 August 2026:

Dosage form: CAPSULE

Route: ORAL

Source for this answer

Who is the recorded registrant for NINLARO CAPSULE 2.3mg?

According to the HSA dataset updated 7 August 2026:

Registrant: TAKEDA PHARMACEUTICALS (ASIA PACIFIC) PTE. LTD.

Source for this answer

Which manufacturers and countries are listed for NINLARO CAPSULE 2.3mg?

According to the HSA dataset updated 7 August 2026:

Manufacturer(s):

  • HAUPT PHARMA AMAREG GMBH
  • Takeda Ireland Ltd.

Manufacturing country/countries: IRELAND; GERMANY

Source for this answer

Where can I look up NINLARO CAPSULE 2.3mg in the HSA register?

Open HSA’s therapeutic product register and search for registration number SIN15162P or the exact product name NINLARO CAPSULE 2.3mg. The general register link does not preselect this product.

Source for this answer

What are the source dates for this NINLARO CAPSULE 2.3mg record?

This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.

The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.

Source for this answer

Has this NINLARO CAPSULE 2.3mg record had a separate HSA register check?

No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.

Search the HSA register using SIN15162P for the latest record.

Source for this answer

Sources and dates

HSA dataset: 2026. Updated: 13 November 2026.

Factual product information only; no dosing, treatment or suitability advice.

Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.

bottom of page